Home › Atherosclerosis › Texas › Amarillo
Atherosclerosis clinical trials in Amarillo, TX
6 studies for Atherosclerosis are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- PharmaTex Research, Amarillo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- PharmaTex Research, LLC, Amarillo
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- PharmaTex Research, LLC, Amarillo
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Amarillo
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- PharmaTex Research LLC, Amarillo
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Pharma Tex Research, Amarillo
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Houston, TX10 studies
- Boston, MA10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Durham, NC7 studies
- Las Vegas, NV7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Memphis, TN7 studies
- Omaha, NE6 studies
Other studies in Amarillo
- Obesity10 studies
- Non-Small Cell Lung Cancer8 studies
- Heart Failure8 studies
- Overweight7 studies
- Lung Cancer5 studies
- Cardiovascular Disease5 studies
- Blood Clots4 studies
- Breast Cancer3 studies
- Digestive Diseases3 studies
- Colorectal Cancer3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.